公开(公告)号：EP2859896B1

公开(公告)日：2018-01-31

申请号：EP13187712.8

申请日：2013-10-08

Applicant: Ystem S.r.l. ,  U.G.A. Nutraceuticals S.r.l. unipersonale

Inventor： Torrente, Yvan ,  Selimi, Gentian ,  Fabrizi, Francesco

IPC: A61K31/7048 ,  A61K31/12 ,  A61K31/122 ,  A61K31/202 ,  A61K31/205 ,  A61K31/221 ,  A61K31/352 ,  A61K31/353 ,  A61K31/355 ,  A61K31/375 ,  A61K36/82 ,  A61K36/539 ,  A61P21/00

CPC classification number: A61K31/352 ,  A23L33/105 ,  A23V2002/00 ,  A61K9/08 ,  A61K9/145 ,  A61K31/12 ,  A61K31/122 ,  A61K31/202 ,  A61K31/221 ,  A61K31/353 ,  A61K31/355 ,  A61K31/375 ,  A61K36/539 ,  A61K36/82 ,  A61K47/26 ,  A61K47/44 ,  A61K2300/00 ,  A23V2200/316 ,  A23V2250/0612 ,  A23V2250/1868 ,  A23V2250/187 ,  A23V2250/21 ,  A23V2250/2112 ,  A23V2250/214 ,  A23V2250/314 ,  A23V2250/708 ,  A23V2250/712

Abstract: Here we described nutritional supplements containing baicalin, curcumin, green tea catechins, vitamin E, vitamin C, coenzyme Q10, L-acetyl-carnitine, DHA, EPA and their methods of use in improving muscle function, endurance and physical performance after exercise. The nutritional supplements can be used to enhance endurance capacity and muscle recovery, to increase muscle mass, preventing muscle loss, to reduce muscle fatigue, maintaining muscle performance, muscle strength, and/or muscle function. Moreover they are able to prevent catabolism (muscle atrophy or wasting) when administrated to a mammalian subject.

公开(公告)号：EP2384192B1

公开(公告)日：2017-10-25

申请号：EP10700011.9

申请日：2010-01-04

Applicant: Calanus AS

Inventor： RAA, Jan ,  RØRSTAD, Gunnar ,  TANDE, Kurt, Steinar

IPC: A61K31/122 ,  A61K31/202 ,  A61K31/232 ,  A61P9/00 ,  A61P9/10 ,  A23D9/00 ,  A23L33/115

CPC classification number: A61K31/202 ,  A23D9/013 ,  A23L33/115 ,  A23V2002/00 ,  A61K31/045 ,  A61K31/122 ,  A61K31/201 ,  A61K31/232 ,  A61K35/56 ,  A61K2300/00 ,  A23V2200/326 ,  A23V2200/3262 ,  A23V2250/187 ,  A23V2250/1868

Abstract: This invention relates to a biological oil composition, preferably obtained from a copepod, most preferably the copepod Calanus finmarchicus and the use thereof to prevent or treat formation of atherosclerotic plaques and hence development of coronary heart disease. The composition comprises the same marine n-3 polyunsaturated fatty acids (PUFAs) generally regarded as being responsible for the anti-atherosclerotic effect of marine oils, namely EPA (C20:5n-3 eicosapentaenoic acid) and DHA (C22:6n-3 docosahexaenoic acid). However, quite unexpectedly, it has been found that the oil composition of the present invention has a remarkably higher ability to prevent formation of atherosclerotic plaques than what can be attributed to EPA and DHA alone, and moreover, unlike EPA and DHA alone it has a notable blood cholesterol lowering effect.

公开(公告)号：EP2547217B1

公开(公告)日：2017-07-19

申请号：EP11712043.6

申请日：2011-03-17

Applicant: N.V. Nutricia

Inventor： VAN DER BEEK, Eline Marleen ,  ABRAHAMSE-BERKEVELD, Marieke ,  SCHIPPER, Annemiek Lidewij ,  SPEELMANS, Gelske

IPC: A23D7/01 ,  A23D9/05 ,  A23J7/00 ,  A61K31/201 ,  A61K31/683 ,  A23L33/00 ,  A23L33/12 ,  A23L33/115 ,  A23P10/35 ,  A23D9/013 ,  A61K9/00 ,  A61K31/202 ,  A61K31/685

CPC classification number: A61K31/202 ,  A23D7/011 ,  A23D9/013 ,  A23D9/05 ,  A23L33/115 ,  A23L33/12 ,  A23L33/40 ,  A23P10/35 ,  A23V2002/00 ,  A61K9/0087 ,  A61K31/201 ,  A61K31/575 ,  A61K31/683 ,  A61K31/685 ,  A61K2300/00 ,  A23V2200/322 ,  A23V2250/1882 ,  A23V2250/1868 ,  A23V2250/187 ,  A23V2200/224 ,  A23V2200/222 ,  A23V2200/254

Abstract: The present invention relates to infant nutrition, in particular to infant nutrition comprising special lipid globules for improvement of the fatty acid composition in brain membranes.

Abstract translation: 本发明涉及婴儿营养，特别涉及包含用于改善脑膜中脂肪酸组成的特殊脂质球的婴儿营养。

公开(公告)号：EP3131408A1

公开(公告)日：2017-02-22

申请号：EP15779399.3

申请日：2015-04-16

Applicant: Savage River, Inc. Dba Beyond Meat

Inventor： ANDERSON, David ,  FULLER, Justin ,  GEISTLINGER, Timothy

IPC: A23J3/14 ,  A23J3/22

CPC classification number: A23J3/227 ,  A23J3/14 ,  A23V2002/00 ,  A23V2250/1578 ,  A23V2250/1592 ,  A23V2250/1868 ,  A23V2250/187 ,  A23V2250/548 ,  A23V2250/706 ,  A23V2300/08 ,  A23V2300/16 ,  A23V2300/41

Abstract: Provided are nutrient-dense meat structured protein products providing complete sources of protein and essential nutrients. Also provided are methods and processes for producing such nutrient-dense meat structured protein products. Also provided are nutrient-dense condiments that can be packaged with meat structured protein products or nutrient-dense meat structured protein products.

Abstract translation: 提供营养密集的肉结构蛋白质产品，提供蛋白质和必需营养素的完整来源。 还提供了用于生产这种营养稠密肉结构蛋白产品的方法和方法。 还提供了可与肉结构蛋白质产品或营养密集的肉结构蛋白质产品一起包装的营养密集调味品。

公开(公告)号：EP2994165A4

公开(公告)日：2017-01-04

申请号：EP14794423

申请日：2014-05-12

Applicant: NITROMEGA CORP

Inventor： MILLER RAYMOND A ,  SHELTON THOMAS B

IPC: A61K45/00 ,  A23L19/00 ,  A23L33/10 ,  A23L33/115 ,  A23L33/12 ,  A23P10/30 ,  A61K9/48 ,  A61K31/202 ,  A61K33/00 ,  A61K36/21 ,  A61K45/06

CPC classification number: A61K31/202 ,  A23L19/09 ,  A23L33/10 ,  A23L33/115 ,  A23L33/12 ,  A23P10/30 ,  A23V2002/00 ,  A61K9/48 ,  A61K33/00 ,  A61K36/21 ,  A61K45/06 ,  A23V2200/326 ,  A23V2250/1868 ,  A23V2250/187

公开(公告)号：EP2408316B1

公开(公告)日：2017-01-04

申请号：EP09789517.1

申请日：2009-03-16

Applicant: Monsanto Technology LLC

Inventor： HARTNELL, Gary, F ,  URSIN, Virginia, M

IPC: A23K50/00 ,  A23K50/70 ,  A23K20/00

CPC classification number: A23K50/75 ,  A23K20/158 ,  A23L13/50 ,  A23L15/20 ,  A23L33/12 ,  A23V2002/00 ,  A23V2200/30 ,  A23V2250/1882 ,  A23V2250/187 ,  A23V2250/1868 ,  A23V2250/1874

公开(公告)号：EP3046552A1

公开(公告)日：2016-07-27

申请号：EP14744782.5

申请日：2014-07-02

Applicant: International Nutrition Research Company

Inventor： VINCENT, Claude

IPC: A61K31/155 ,  A61K31/366 ,  A61K31/7016 ,  A61K33/00 ,  A61P3/04 ,  A61K38/01 ,  A61K38/38 ,  A61K38/08 ,  A61K31/4415 ,  A61K33/06 ,  A61K35/20 ,  A61P3/00 ,  A23L33/00

CPC classification number: A61K35/20 ,  A23L33/15 ,  A23L33/155 ,  A23L33/16 ,  A23L33/175 ,  A23L33/18 ,  A23L33/19 ,  A23V2002/00 ,  A61K9/0053 ,  A61K31/155 ,  A61K31/198 ,  A61K31/202 ,  A61K31/355 ,  A61K31/366 ,  A61K31/401 ,  A61K31/405 ,  A61K31/426 ,  A61K31/4375 ,  A61K31/4415 ,  A61K31/59 ,  A61K33/04 ,  A61K33/06 ,  A61K33/30 ,  A61K38/06 ,  A61K38/08 ,  A61K38/193 ,  A61K38/38 ,  A61K38/446 ,  A61K2300/00 ,  C12Y115/01001 ,  A23V2200/326 ,  A23V2200/328 ,  A23V2250/0604 ,  A23V2250/062 ,  A23V2250/0626 ,  A23V2250/0628 ,  A23V2250/065 ,  A23V2250/1578 ,  A23V2250/187 ,  A23V2250/1882 ,  A23V2250/5424 ,  A23V2250/54242 ,  A23V2250/55 ,  A23V2250/7052 ,  A23V2250/7056 ,  A23V2250/71 ,  A23V2250/712

Abstract: The invention relates to a composition suitable for use as a health product, comprising a mixture of active ingredients made up of at least: - a lactoserum hydrolysate with a molecular weight comprised between 200 and 5000 daltons, - alpha-lactalbumin, - at least one AMPK, MAPK, PPAR and/or SIRT1 cycle regulator, - milk calcium. It is particularly useful as a medical nutrition product or orally administered drug, to prevent and/or combat various diseases.

Abstract translation: 乳清水解产物，200个5000道尔顿，α-乳清蛋白，至少一种AMPK，MAPK，PPAR和/或之间的分子量：适于用作医疗产品，包括由至少的活性成分的混合物的组合物 SIRT1周期调节，和牛奶中的钙。 该组合物是作为医疗营养产品或口服给药的药物是特别有用的，以预防和/或防治各种疾病。

公开(公告)号：EP2296643B1

公开(公告)日：2016-04-20

申请号：EP09770430.8

申请日：2009-06-23

Applicant: N.V. Nutricia

Inventor： FABER, Joyce ,  VAN HELVOORT, Adrianus Lambertus Bertholdus ,  VAN NORREN, Klaske ,  VOS, Arjan Paul ,  HAGEMAN, Robert Johan Joseph ,  VAN LIMPT, Cornelus Johannes Petrus

IPC: A61K38/01 ,  A61K38/02 ,  A61K45/06 ,  A61K31/202 ,  A61K31/702 ,  A61K39/39 ,  A61K47/12 ,  A61K47/42 ,  A61K39/00

CPC classification number: A61K39/39 ,  A23L33/12 ,  A23L33/175 ,  A23L33/19 ,  A23L33/40 ,  A23V2002/00 ,  A61K31/198 ,  A61K31/202 ,  A61K31/702 ,  A61K35/20 ,  A61K38/018 ,  A61K38/02 ,  A61K45/06 ,  A61K47/12 ,  A61K47/42 ,  A61K2039/55583 ,  A61K2300/00 ,  A23V2250/54252 ,  A23V2250/54246 ,  A23V2250/0628 ,  A23V2250/28 ,  A23V2250/1868 ,  A23V2250/187 ,  A23V2200/324

公开(公告)号：EP2934505A1

公开(公告)日：2015-10-28

申请号：EP13867433.8

申请日：2013-12-18

Applicant: Qualitas Health, Ltd.

Inventor： WAIBEL, Brian J. ,  SCHONEMANN, Hans ,  KRUKONIS, Val ,  KAGAN, Michael

IPC: A61K31/202 ,  A61P9/00 ,  A61P25/00 ,  A61K36/05

CPC classification number: A61K31/232 ,  A23D9/013 ,  A23L33/12 ,  A23V2002/00 ,  A61K31/20 ,  A61K31/201 ,  A61K31/202 ,  A61K31/555 ,  A61K31/683 ,  A61K31/685 ,  A61K31/7032 ,  A61K36/05 ,  A61K45/06 ,  C11B1/10 ,  C11B1/104 ,  C11B3/00 ,  C11B7/00 ,  C11B7/0025 ,  C11B7/005 ,  A61K2300/00 ,  A23V2200/32 ,  A23V2200/322 ,  A23V2200/326 ,  A23V2250/1846 ,  A23V2250/1848 ,  A23V2250/185 ,  A23V2250/187 ,  A23V2250/2136 ,  A23V2250/314

Abstract: Provided herein are compositions comprising eicosapentaenoic acid (EPA) and polar lipids (e.g., glycolipids and phospholipids), and which do not contain any docosahexaenoic acid (DHA) or esterified fatty acids.

公开(公告)号：EP1272058B1

公开(公告)日：2015-06-24

申请号：EP01928487.6

申请日：2001-04-12

Applicant: ABBOTT LABORATORIES

Inventor： O'CONNER, Deborah L. ,  AUESTAD, Nancy ,  MERRITT, Russell J. ,  FITZGERALD-GUSTAFSON, Kathleen ,  HALTER, Robin ,  JANOWSKY, Jeri ,  NEURINGER, Martha ,  SINGER, Lynn T.

IPC: A23L1/29 ,  A23L1/30

CPC classification number: A23L33/12 ,  A23L33/40 ,  A23V2002/00 ,  A23V2200/322 ,  A23V2250/1862 ,  A23V2250/1868 ,  A23V2250/1872 ,  A23V2250/1874 ,  A23V2250/187 ,  A23V2250/211 ,  A23V2250/712